Reverend Anthony J. Hillelson, who has rheumatoid arthritis, on why he lobbies Congress to support rheumatic disease research funding
ACR 2013 State-of-the-Art Clinical Symposium: How to Identify Signs of Myositis and Metabolic Myopathies
Rheumatologists offer tips for diagnosing and treating these diseases
ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?
Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)
ACR 2013 State-of-the-Art Clinical Symposium: Diagnosis and Management of Vasculitis
The latest on Behçet’s syndrome, infectious arthritis, and central nervous system vasculitis
Healthcare Providers Must Get Compliant with HIPAA Privacy Practices
Failure to have an updated Notice of Privacy Practices by September 23, 2013 could result in fines and penalties
New Methodology to Improve Cartilage Repair
A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells. (posted July 31, 2013)
B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)
Congress Considers More Regulation for Manufacturers of Compounding Drugs
New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)
President’s Perspective: Will the Physician Payment Sunshine Act Shed Light on Conflicts of Interest?
What rheumatologists should know about complying with the PPSA when it goes into effect on August 1
How Rheumatologists Can Connect with Congress during August Recess
Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices
- « Previous Page
- 1
- …
- 231
- 232
- 233
- 234
- 235
- …
- 300
- Next Page »